Let's get more solutions to patients. The Johnson & Johnson Innovation, JLABS (JLABS) Meet with… Series helps life sciences entrepreneurs, as well as the academic community, connect with potential partners including corporate venture, VC's, Angels and other investment entities.
On December 7th, Paulina Hill, Principal at Polaris Partners will be in attendance to give an overview presentation about their company's key areas of interest and to meet 1-on-1 with companies that have been accepted after applying online.
*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due November 9th, 2017. Apply Here.
For over twenty years, Polaris has sought out the best entrepreneurs. Polaris Partners invest throughout the company life cycle — from the earliest stages of company creation through profitability — working closely with the teams to reach their goals.
They invest in transformative technology, biological science and innovative business models where they have deep experience and success — as investors, board members, scientists, operators and entrepreneurs.
Investment areas of interest that meet the critical needs of patients worldwide and areas which change lives include:
- Novel therapeutics
- Platform biotechnology
- Drug delivery
- Diagnostics and medical devices
Following the presentation, don't miss this opportunity to introduce yourself to Paulina during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with Polaris Partners will provide an intimate forum to discuss your company.
10:30 AM | Registration and Networking
11:00 AM | Presentation and Q&A
12:00 PM | Networking and Lunch
12:30 PM – 5:00 PM | One-on-one Meetings*
$15 | General Public
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on December 6th (or sold out).
JLABS @ Toronto
661 University Ave, Suite 1300
Polaris Partners Representative:
Paulina Hill | Principal, Polaris Partners
Paulina Hill joined Polaris in 2012 and focuses on investments in healthcare from the Boston office. Paulina serves on the boards of Arsenal Medical, Faraday Pharmaceuticals, Kala Pharmaceuticals (NASDAQ:KALA), KinDex Pharmaceuticals, Marauder Therapeutics and Neuronetics. She is an observer on the boards of 480 Biomedical, Microchips Biotech and Sofregen. In addition to her investing role, Paulina has served as founding CEO of Polaris-backed Marauder Therapeutics, a biotech startup based in Cambridge, MA. She also serves on the board of The Capital Network, a non-profit that provides fundraising education to startup entrepreneurs.
Prior to joining Polaris, Paulina completed her postdoctoral fellowship in the Chemical Engineering department at MIT in Bob Langer’s lab. Paulina is the founding President of the MIT Postdoctoral Association and served on the MIT Intellectual Property Presidential Committee. Paulina completed her PhD in Molecular Medicine with a Tissue Engineering focus at Wake Forest University School of Medicine. Paulina graduated magna cum laude from East Carolina University with a quadruple major in biochemistry, neuroscience, biology and chemistry. ECU honored Paulina with the Incredible Women’s award in 2017. Paulina was born in Poland and grew up in Toronto. She attended East Carolina on an athletic scholarship, serving as Captain of the women’s tennis team.Back to all